Global Genotyping Market- Industry Analysis and Forecast (2020-2027) – By Product, Technology, End User, and Region.

Global Genotyping Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of XX % during a forecast period. Global Genotyping Market To know about the Research Methodology :- Request Free Sample Report Genotyping includes the detection or mapping process of small genetic. It is the process of studying DNA sequence to determine the genetic constitution in the genotypes of living organisms like humans, plants, animals, and microorganisms.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

Global Genotyping Market Drivers and Restraints:

Technical advancements in the genotyping process are helping for miniaturization, automation, and reduction of the overall costs and operational flexibility. An increase in the technological advances in DNA sequencing like NGS is presenting rapid, accurate sequencing and high production, which are expected to drive the market growth. On the other hand, Genotyping instruments are prepared with advanced features and functionalities, which makes them an expensive cost. Pharmaceutical companies and research laboratories are requiring significant investments for procuring multiple, high-cost genotyping instruments. Also, maintenance costs and several other indirect expenses like sample and labor costs are some of the factors, which are increasing the overall cost. As a result, the high cost of the genotyping instruments is expected to limit the growth in the market. The technological advancements towards the development of innovative and efficient procedures for genotyping are expected to create lucrative opportunities for market key players. An introduction of automated sequencing models and high-throughput platforms deliver potential growth opportunities in the arena of clinical molecular modeling studies, new chemical entity interactions, and genome sequencing. The reagents & kits segment is expected to dominate the market during the forecast period (2020-2027). The dominant position in the market is attributed to the presence of the major high throughput platforms MiniSeq, MiSeq, iSeq, NextSeq, HiSeq X, and NovaSeq series from leading key players. Continuous developments in the enhancement of library preparation workflow are expected to drive the reagents & kits segment. Today, researchers have a wide variety of technologies for collecting genetic information. Array-based approaches are the method of choice in analyzing the genome for many plants and animals. As sequencing costs continue to decline, new approaches, which influence next-generation sequencing (NGS) technology is developing to perform genotyping studies. The sequencing segment is expected to share US $ XX Mn in the global genotyping market during the forecast period (2020-2027). The term next-generation sequencing-based genotyping (NGG) or sequence-based genotyping includes genotyping methods, which leverage NGS technology. NGG contains targeted, reduced representation, and hybridization-based approaches to determine and genotype SNPs in many individuals or specimens. The rapid development of sequencing technology has resulted in higher throughput and a lower cost per sample. The NGG is a cost-effective tool for genotype screening, genetic mapping, purity testing, screening backcross lines, constructing haplotype maps, and performing association mapping and genomic selection. The Diagnostic & Research Laboratories are expected to share significant growth in the genotyping market. The rise in penetration of high throughput technology-based diagnostic tests, which are CLIA waived or are under the process of clinical approval is expected to influence market growth. Region-wise, North America region is expected to contribute US $ XX Mn share in the global genotyping market. An increase in adoption of the technologically advanced genotyping products, presence of advanced healthcare infrastructure and developed healthcare systems in the US and Canada are expected to boost the growth in the market. Also, the existence of a large number of leading genotyping manufacturers, genotyping-based R&D projects, and rise in demand from pharmaceutical companies for genotyping products is some of the factors, which are responsible for the large share of the genotyping market in the region. The objective of the report is to present a comprehensive analysis of Global Genotyping Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Genotyping Market dynamics, structure by analysing the market segments and project the Global Genotyping Market size. Clear representation of competitive analysis of key players by Type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Genotyping Market make the report investor’s guide.

The Scope of the Report for Global Genotyping Market: Inquire before buying

Global Genotyping Market, By Product

• Reagents & Kits • Genotyping Services • Instruments  Sequencers & Amplifiers    Analyzers • Others

Global Genotyping Market, By Technology

• Microarrays • Capillary Electrophoresis      Amplified Fragment Length Polymorphism (AFLP)     Restriction Fragment Length Polymorphism (RFLP)     Single-Strand Conformation Polymorphism (SSCP) • Polymerase Chain Reaction (PCR) Real-Time PCR   Digital PCR • Sequencing Next-Generation Sequencing   Pyrosequencing   Sanger Sequencing • MALDI-TOF • Allele Specific Oligonucleotide (ASO) Probes • Others

Global Genotyping Market, By End User

• Pharmaceutical & Biopharmaceutical Companies • Diagnostic & Research Laboratories • Academic Institutes

Global Genotyping Market, By Region

• North America • Europe • Asia Pacific • Middle East & Africa • South America

Key players operating in Global Genotyping Market

• GE Healthcare GmbH • Illumina, Inc. • Beckman Coulter, Inc. • Life Technologies Corporation • ThermoFisher Scientific, Inc. • Eurofins Scientific • Qiagen NV • Roche Diagnostics • Affymetrix, Inc. • Agilent Technologies, Inc. • Genewiz, Inc. • Fludigm Corporation • Bio-Rad Laboratories, INC. • Sequenom, Inc. • Bioline • Danaher • F. Hoffmann-La Roche Ltd. • Sequenom • Biogeniq Inc. • Envigo • LGC Biosearch Technologies
Global Genotyping Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Genotyping Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Genotyping Market Analysis and Forecast 6.1. Genotyping Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Genotyping Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Genotyping Market Value Share Analysis, by Product 7.4. Genotyping Market Size (US$ Bn) Forecast, by Product 7.5. Genotyping Market Analysis, by Product 7.6. Genotyping Market Attractiveness Analysis, by Product 8. Global Genotyping Market Analysis and Forecast, by Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Genotyping Market Value Share Analysis, by Technology 8.4. Genotyping Market Size (US$ Bn) Forecast, by Technology 8.5. Genotyping Market Analysis, by Technology 8.6. Genotyping Market Attractiveness Analysis, by Technology 9. Global Genotyping Market Analysis and Forecast, by End User 9.1. Introduction and Definition 9.2. Key Findings 9.3. Genotyping Market Value Share Analysis, by End User 9.4. Genotyping Market Size (US$ Bn) Forecast, by End User 9.5. Genotyping Market Analysis, by End User 9.6. Genotyping Market Attractiveness Analysis, by End User 10. Global Genotyping Market Analysis, by Region 10.1. Genotyping Market Value Share Analysis, by Region 10.2. Genotyping Market Size (US$ Bn) Forecast, by Region 10.3. Genotyping Market Attractiveness Analysis, by Region 11. North America Genotyping Market Analysis 11.1. Key Findings 11.2. North America Genotyping Market Overview 11.3. North America Genotyping Market Value Share Analysis, by Product 11.4. North America Genotyping Market Forecast, by Product 11.4.1. Reagents & Kits 11.4.2. Genotyping Services 11.4.3. Instruments 11.4.3.1. Sequencers & Amplifiers 11.4.3.2. Analyzers 11.4.4. Others 11.5. North America Genotyping Market Value Share Analysis, by Technology 11.6. North America Genotyping Market Forecast, by Technology 11.6.1. Microarrays 11.6.2. Capillary Electrophoresis 11.6.2.1. Amplified Fragment Length Polymorphism (AFLP) 11.6.2.2. Restriction Fragment Length Polymorphism (RFLP) 11.6.2.3. Single-Strand Conformation Polymorphism (SSCP) 11.6.3. Polymerase Chain Reaction (PCR) 11.6.3.1. Real-Time PCR 11.6.3.2. Digital PCR 11.6.4. Sequencing 11.6.4.1. Next-Generation Sequencing 11.6.4.2. Pyrosequencing 11.6.4.3. Sanger Sequencing 11.6.5. MALDI-TOF 11.6.6. Allele Specific Oligonucleotide (ASO) Probes 11.6.7. Others 11.7. North America Genotyping Market Value Share Analysis, by End User 11.8. North America Genotyping Market Forecast, by End User 11.8.1. Pharmaceutical & Biopharmaceutical Companies 11.8.2. Diagnostic & Research Laboratories 11.8.3. Academic Institutes 11.9. North America Genotyping Market Value Share Analysis, by Country 11.10. North America Genotyping Market Forecast, by Country 11.10.1. U.S. 11.10.2. Canada 11.11. North America Genotyping Market Analysis, by Country 11.12. U.S. Genotyping Market Forecast, by Product 11.12.1. Reagents & Kits 11.12.2. Genotyping Services 11.12.3. Instruments 11.12.3.1. Sequencers & Amplifiers 11.12.3.2. Analyzers 11.12.4. Others 11.13. U.S. Genotyping Market Forecast, by Technology 11.13.1. Microarrays 11.13.2. Capillary Electrophoresis 11.13.2.1. Amplified Fragment Length Polymorphism (AFLP) 11.13.2.2. Restriction Fragment Length Polymorphism (RFLP) 11.13.2.3. Single-Strand Conformation Polymorphism (SSCP) 11.13.3. Polymerase Chain Reaction (PCR) 11.13.3.1. Real-Time PCR 11.13.3.2. Digital PCR 11.13.4. Sequencing 11.13.4.1. Next-Generation Sequencing 11.13.4.2. Pyrosequencing 11.13.4.3. Sanger Sequencing 11.13.5. MALDI-TOF 11.13.6. Allele Specific Oligonucleotide (ASO) Probes 11.13.7. Others 11.14. U.S. Genotyping Market Forecast, by End User 11.14.1. Pharmaceutical & Biopharmaceutical Companies 11.14.2. Diagnostic & Research Laboratories 11.14.3. Academic Institutes 11.15. Canada Genotyping Market Forecast, by Product 11.15.1. Reagents & Kits 11.15.2. Genotyping Services 11.15.3. Instruments 11.15.3.1. Sequencers & Amplifiers 11.15.3.2. Analyzers 11.15.4. Others 11.16. Canada Genotyping Market Forecast, by Technology 11.16.1. Microarrays 11.16.2. Capillary Electrophoresis 11.16.2.1. Amplified Fragment Length Polymorphism (AFLP) 11.16.2.2. Restriction Fragment Length Polymorphism (RFLP) 11.16.2.3. Single-Strand Conformation Polymorphism (SSCP) 11.16.3. Polymerase Chain Reaction (PCR) 11.16.3.1. Real-Time PCR 11.16.3.2. Digital PCR 11.16.4. Sequencing 11.16.4.1. Next-Generation Sequencing 11.16.4.2. Pyrosequencing 11.16.4.3. Sanger Sequencing 11.16.5. MALDI-TOF 11.16.6. Allele Specific Oligonucleotide (ASO) Probes 11.16.7. Others 11.17. Canada Genotyping Market Forecast, by End User 11.17.1. Pharmaceutical & Biopharmaceutical Companies 11.17.2. Diagnostic & Research Laboratories 11.17.3. Academic Institutes 11.18. North America Genotyping Market Attractiveness Analysis 11.18.1. By Product 11.18.2. By Technology 11.18.3. By End User 11.19. PEST Analysis 11.20. Key Trends 11.21. Key Developments 12. Europe Genotyping Market Analysis 12.1. Key Findings 12.2. Europe Genotyping Market Overview 12.3. Europe Genotyping Market Value Share Analysis, by Product 12.4. Europe Genotyping Market Forecast, by Product 12.4.1. Reagents & Kits 12.4.2. Genotyping Services 12.4.3. Instruments 12.4.3.1. Sequencers & Amplifiers 12.4.3.2. Analyzers 12.4.4. Others 12.5. Europe Genotyping Market Value Share Analysis, by Technology 12.6. Europe Genotyping Market Forecast, by Technology 12.6.1. Microarrays 12.6.2. Capillary Electrophoresis 12.6.2.1. Amplified Fragment Length Polymorphism (AFLP) 12.6.2.2. Restriction Fragment Length Polymorphism (RFLP) 12.6.2.3. Single-Strand Conformation Polymorphism (SSCP) 12.6.3. Polymerase Chain Reaction (PCR) 12.6.3.1. Real-Time PCR 12.6.3.2. Digital PCR 12.6.4. Sequencing 12.6.4.1. Next-Generation Sequencing 12.6.4.2. Pyrosequencing 12.6.4.3. Sanger Sequencing 12.6.5. MALDI-TOF 12.6.6. Allele Specific Oligonucleotide (ASO) Probes 12.6.7. Others 12.7. Europe Genotyping Market Value Share Analysis, by End User 12.8. Europe Genotyping Market Forecast, by End User 12.8.1. Pharmaceutical & Biopharmaceutical Companies 12.8.2. Diagnostic & Research Laboratories 12.8.3. Academic Institutes 12.9. Europe Genotyping Market Value Share Analysis, by Country 12.10. Europe Genotyping Market Forecast, by Country 12.10.1. Germany 12.10.2. U.K. 12.10.3. France 12.10.4. Italy 12.10.5. Spain 12.10.6. Rest of Europe 12.11. Europe Genotyping Market Analysis, by Country 12.12. Germany Genotyping Market Forecast, by Product 12.12.1. Reagents & Kits 12.12.2. Genotyping Services 12.12.3. Instruments 12.12.3.1. Sequencers & Amplifiers 12.12.3.2. Analyzers 12.12.4. Others 12.13. Germany Genotyping Market Forecast, by Technology 12.13.1. Microarrays 12.13.2. Capillary Electrophoresis 12.13.2.1. Amplified Fragment Length Polymorphism (AFLP) 12.13.2.2. Restriction Fragment Length Polymorphism (RFLP) 12.13.2.3. Single-Strand Conformation Polymorphism (SSCP) 12.13.3. Polymerase Chain Reaction (PCR) 12.13.3.1. Real-Time PCR 12.13.3.2. Digital PCR 12.13.4. Sequencing 12.13.4.1. Next-Generation Sequencing 12.13.4.2. Pyrosequencing 12.13.4.3. Sanger Sequencing 12.13.5. MALDI-TOF 12.13.6. Allele Specific Oligonucleotide (ASO) Probes 12.13.7. Others 12.14. Germany Genotyping Market Forecast, by End User 12.14.1. Pharmaceutical & Biopharmaceutical Companies 12.14.2. Diagnostic & Research Laboratories 12.14.3. Academic Institutes 12.15. U.K. Genotyping Market Forecast, by Product 12.15.1. Reagents & Kits 12.15.2. Genotyping Services 12.15.3. Instruments 12.15.3.1. Sequencers & Amplifiers 12.15.3.2. Analyzers 12.15.4. Others 12.16. U.K. Genotyping Market Forecast, by Technology 12.16.1. Microarrays 12.16.2. Capillary Electrophoresis 12.16.2.1. Amplified Fragment Length Polymorphism (AFLP) 12.16.2.2. Restriction Fragment Length Polymorphism (RFLP) 12.16.2.3. Single-Strand Conformation Polymorphism (SSCP) 12.16.3. Polymerase Chain Reaction (PCR) 12.16.3.1. Real-Time PCR 12.16.3.2. Digital PCR 12.16.4. Sequencing 12.16.4.1. Next-Generation Sequencing 12.16.4.2. Pyrosequencing 12.16.4.3. Sanger Sequencing 12.16.5. MALDI-TOF 12.16.6. Allele Specific Oligonucleotide (ASO) Probes 12.16.7. Others 12.17. U.K. Genotyping Market Forecast, by End User 12.17.1. Pharmaceutical & Biopharmaceutical Companies 12.17.2. Diagnostic & Research Laboratories 12.17.3. Academic Institutes 12.18. France Genotyping Market Forecast, by Product 12.18.1. Reagents & Kits 12.18.2. Genotyping Services 12.18.3. Instruments 12.18.3.1. Sequencers & Amplifiers 12.18.3.2. Analyzers 12.18.4. Others 12.19. France Genotyping Market Forecast, by Technology 12.19.1. Microarrays 12.19.2. Capillary Electrophoresis 12.19.2.1. Amplified Fragment Length Polymorphism (AFLP) 12.19.2.2. Restriction Fragment Length Polymorphism (RFLP) 12.19.2.3. Single-Strand Conformation Polymorphism (SSCP) 12.19.3. Polymerase Chain Reaction (PCR) 12.19.3.1. Real-Time PCR 12.19.3.2. Digital PCR 12.19.4. Sequencing 12.19.4.1. Next-Generation Sequencing 12.19.4.2. Pyrosequencing 12.19.4.3. Sanger Sequencing 12.19.5. MALDI-TOF 12.19.6. Allele Specific Oligonucleotide (ASO) Probes 12.19.7. Others 12.20. France Genotyping Market Forecast, by End User 12.20.1. Pharmaceutical & Biopharmaceutical Companies 12.20.2. Diagnostic & Research Laboratories 12.20.3. Academic Institutes 12.21. Italy Genotyping Market Forecast, by Product 12.21.1. Reagents & Kits 12.21.2. Genotyping Services 12.21.3. Instruments 12.21.3.1. Sequencers & Amplifiers 12.21.3.2. Analyzers 12.21.4. Others 12.22. Italy Genotyping Market Forecast, by Technology 12.22.1. Microarrays 12.22.2. Capillary Electrophoresis 12.22.2.1. Amplified Fragment Length Polymorphism (AFLP) 12.22.2.2. Restriction Fragment Length Polymorphism (RFLP) 12.22.2.3. Single-Strand Conformation Polymorphism (SSCP) 12.22.3. Polymerase Chain Reaction (PCR) 12.22.3.1. Real-Time PCR 12.22.3.2. Digital PCR 12.22.4. Sequencing 12.22.4.1. Next-Generation Sequencing 12.22.4.2. Pyrosequencing 12.22.4.3. Sanger Sequencing 12.22.5. MALDI-TOF 12.22.6. Allele Specific Oligonucleotide (ASO) Probes 12.22.7. Others 12.23. Italy Genotyping Market Forecast, by End User 12.23.1. Pharmaceutical & Biopharmaceutical Companies 12.23.2. Diagnostic & Research Laboratories 12.23.3. Academic Institutes 12.24. Spain Genotyping Market Forecast, by Product 12.24.1. Reagents & Kits 12.24.2. Genotyping Services 12.24.3. Instruments 12.24.3.1. Sequencers & Amplifiers 12.24.3.2. Analyzers 12.24.4. Others 12.25. Spain Genotyping Market Forecast, by Technology 12.25.1. Microarrays 12.25.2. Capillary Electrophoresis 12.25.2.1. Amplified Fragment Length Polymorphism (AFLP) 12.25.2.2. Restriction Fragment Length Polymorphism (RFLP) 12.25.2.3. Single-Strand Conformation Polymorphism (SSCP) 12.25.3. Polymerase Chain Reaction (PCR) 12.25.3.1. Real-Time PCR 12.25.3.2. Digital PCR 12.25.4. Sequencing 12.25.4.1. Next-Generation Sequencing 12.25.4.2. Pyrosequencing 12.25.4.3. Sanger Sequencing 12.25.5. MALDI-TOF 12.25.6. Allele Specific Oligonucleotide (ASO) Probes 12.25.7. Others 12.26. Spain Genotyping Market Forecast, by End User 12.26.1. Pharmaceutical & Biopharmaceutical Companies 12.26.2. Diagnostic & Research Laboratories 12.26.3. Academic Institutes 12.27. Rest of Europe Genotyping Market Forecast, by Product 12.27.1. Reagents & Kits 12.27.2. Genotyping Services 12.27.3. Instruments 12.27.3.1. Sequencers & Amplifiers 12.27.3.2. Analyzers 12.27.4. Others 12.28. Rest of Europe Genotyping Market Forecast, by Technology 12.28.1. Microarrays 12.28.2. Capillary Electrophoresis 12.28.2.1. Amplified Fragment Length Polymorphism (AFLP) 12.28.2.2. Restriction Fragment Length Polymorphism (RFLP) 12.28.2.3. Single-Strand Conformation Polymorphism (SSCP) 12.28.3. Polymerase Chain Reaction (PCR) 12.28.3.1. Real-Time PCR 12.28.3.2. Digital PCR 12.28.4. Sequencing 12.28.4.1. Next-Generation Sequencing 12.28.4.2. Pyrosequencing 12.28.4.3. Sanger Sequencing 12.28.5. MALDI-TOF 12.28.6. Allele Specific Oligonucleotide (ASO) Probes 12.28.7. Others 12.29. Rest Of Europe Genotyping Market Forecast, by End User 12.29.1. Pharmaceutical & Biopharmaceutical Companies 12.29.2. Diagnostic & Research Laboratories 12.29.3. Academic Institutes 12.30. Europe Genotyping Market Attractiveness Analysis 12.30.1. By Product 12.30.2. By Technology 12.30.3. By End User 12.31. PEST Analysis 12.32. Key Trends 12.33. Key Developments 13. Asia Pacific Genotyping Market Analysis 13.1. Key Findings 13.2. Asia Pacific Genotyping Market Overview 13.3. Asia Pacific Genotyping Market Value Share Analysis, by Product 13.4. Asia Pacific Genotyping Market Forecast, by Product 13.4.1. Reagents & Kits 13.4.2. Genotyping Services 13.4.3. Instruments 13.4.3.1. Sequencers & Amplifiers 13.4.3.2. Analyzers 13.4.4. Others 13.5. Asia Pacific Genotyping Market Value Share Analysis, by Technology 13.6. Asia Pacific Genotyping Market Forecast, by Technology 13.6.1. Microarrays 13.6.2. Capillary Electrophoresis 13.6.2.1. Amplified Fragment Length Polymorphism (AFLP) 13.6.2.2. Restriction Fragment Length Polymorphism (RFLP) 13.6.2.3. Single-Strand Conformation Polymorphism (SSCP) 13.6.3. Polymerase Chain Reaction (PCR) 13.6.3.1. Real-Time PCR 13.6.3.2. Digital PCR 13.6.4. Sequencing 13.6.4.1. Next-Generation Sequencing 13.6.4.2. Pyrosequencing 13.6.4.3. Sanger Sequencing 13.6.5. MALDI-TOF 13.6.6. Allele Specific Oligonucleotide (ASO) Probes 13.6.7. Others 13.7. Asia Pacific Genotyping Market Value Share Analysis, by End User 13.8. Asia Pacific Genotyping Market Forecast, by End User 13.8.1. Pharmaceutical & Biopharmaceutical Companies 13.8.2. Diagnostic & Research Laboratories 13.8.3. Academic Institutes 13.9. Asia Pacific Genotyping Market Value Share Analysis, by Country 13.10. Asia Pacific Genotyping Market Forecast, by Country 13.10.1. China 13.10.2. India 13.10.3. Japan 13.10.4. ASEAN 13.10.5. Rest of Asia Pacific 13.11. Asia Pacific Genotyping Market Analysis, by Country 13.12. China Genotyping Market Forecast, by Product 13.12.1. Reagents & Kits 13.12.2. Genotyping Services 13.12.3. Instruments 13.12.3.1. Sequencers & Amplifiers 13.12.3.2. Analyzers 13.12.4. Others 13.13. China Genotyping Market Forecast, by Technology 13.13.1. Microarrays 13.13.2. Capillary Electrophoresis 13.13.2.1. Amplified Fragment Length Polymorphism (AFLP) 13.13.2.2. Restriction Fragment Length Polymorphism (RFLP) 13.13.2.3. Single-Strand Conformation Polymorphism (SSCP) 13.13.3. Polymerase Chain Reaction (PCR) 13.13.3.1. Real-Time PCR 13.13.3.2. Digital PCR 13.13.4. Sequencing 13.13.4.1. Next-Generation Sequencing 13.13.4.2. Pyrosequencing 13.13.4.3. Sanger Sequencing 13.13.5. MALDI-TOF 13.13.6. Allele Specific Oligonucleotide (ASO) Probes 13.13.7. Others 13.14. China Genotyping Market Forecast, by End User 13.14.1. Pharmaceutical & Biopharmaceutical Companies 13.14.2. Diagnostic & Research Laboratories 13.14.3. Academic Institutes 13.15. India Genotyping Market Forecast, by Product 13.15.1. Reagents & Kits 13.15.2. Genotyping Services 13.15.3. Instruments 13.15.3.1. Sequencers & Amplifiers 13.15.3.2. Analyzers 13.15.4. Others 13.16. India Genotyping Market Forecast, by Technology 13.16.1. Microarrays 13.16.2. Capillary Electrophoresis 13.16.2.1. Amplified Fragment Length Polymorphism (AFLP) 13.16.2.2. Restriction Fragment Length Polymorphism (RFLP) 13.16.2.3. Single-Strand Conformation Polymorphism (SSCP) 13.16.3. Polymerase Chain Reaction (PCR) 13.16.3.1. Real-Time PCR 13.16.3.2. Digital PCR 13.16.4. Sequencing 13.16.4.1. Next-Generation Sequencing 13.16.4.2. Pyrosequencing 13.16.4.3. Sanger Sequencing 13.16.5. MALDI-TOF 13.16.6. Allele Specific Oligonucleotide (ASO) Probes 13.16.7. Others 13.17. India Genotyping Market Forecast, by End User 13.17.1. Pharmaceutical & Biopharmaceutical Companies 13.17.2. Diagnostic & Research Laboratories 13.17.3. Academic Institutes 13.18. Japan Genotyping Market Forecast, by Product 13.18.1. Reagents & Kits 13.18.2. Genotyping Services 13.18.3. Instruments 13.18.3.1. Sequencers & Amplifiers 13.18.3.2. Analyzers 13.18.4. Others 13.19. Japan Genotyping Market Forecast, by Technology 13.19.1. Microarrays 13.19.2. Capillary Electrophoresis 13.19.2.1. Amplified Fragment Length Polymorphism (AFLP) 13.19.2.2. Restriction Fragment Length Polymorphism (RFLP) 13.19.2.3. Single-Strand Conformation Polymorphism (SSCP) 13.19.3. Polymerase Chain Reaction (PCR) 13.19.3.1. Real-Time PCR 13.19.3.2. Digital PCR 13.19.4. Sequencing 13.19.4.1. Next-Generation Sequencing 13.19.4.2. Pyrosequencing 13.19.4.3. Sanger Sequencing 13.19.5. MALDI-TOF 13.19.6. Allele Specific Oligonucleotide (ASO) Probes 13.19.7. Others 13.20. Japan Genotyping Market Forecast, by End User 13.20.1. Pharmaceutical & Biopharmaceutical Companies 13.20.2. Diagnostic & Research Laboratories 13.20.3. Academic Institutes 13.21. ASEAN Genotyping Market Forecast, by Product 13.21.1. Reagents & Kits 13.21.2. Genotyping Services 13.21.3. Instruments 13.21.3.1. Sequencers & Amplifiers 13.21.3.2. Analyzers 13.21.4. Others 13.22. ASEAN Genotyping Market Forecast, by Technology 13.22.1. Microarrays 13.22.2. Capillary Electrophoresis 13.22.2.1. Amplified Fragment Length Polymorphism (AFLP) 13.22.2.2. Restriction Fragment Length Polymorphism (RFLP) 13.22.2.3. Single-Strand Conformation Polymorphism (SSCP) 13.22.3. Polymerase Chain Reaction (PCR) 13.22.3.1. Real-Time PCR 13.22.3.2. Digital PCR 13.22.4. Sequencing 13.22.4.1. Next-Generation Sequencing 13.22.4.2. Pyrosequencing 13.22.4.3. Sanger Sequencing 13.22.5. MALDI-TOF 13.22.6. Allele Specific Oligonucleotide (ASO) Probes 13.22.7. Others 13.23. ASEAN Genotyping Market Forecast, by End User 13.23.1. Pharmaceutical & Biopharmaceutical Companies 13.23.2. Diagnostic & Research Laboratories 13.23.3. Academic Institutes 13.24. Rest of Asia Pacific Genotyping Market Forecast, by Product 13.24.1. Reagents & Kits 13.24.2. Genotyping Services 13.24.3. Instruments 13.24.3.1. Sequencers & Amplifiers 13.24.3.2. Analyzers 13.24.4. Others 13.25. Rest of Asia Pacific Genotyping Market Forecast, by Technology 13.25.1. Microarrays 13.25.2. Capillary Electrophoresis 13.25.2.1. Amplified Fragment Length Polymorphism (AFLP) 13.25.2.2. Restriction Fragment Length Polymorphism (RFLP) 13.25.2.3. Single-Strand Conformation Polymorphism (SSCP) 13.25.3. Polymerase Chain Reaction (PCR) 13.25.3.1. Real-Time PCR 13.25.3.2. Digital PCR 13.25.4. Sequencing 13.25.4.1. Next-Generation Sequencing 13.25.4.2. Pyrosequencing 13.25.4.3. Sanger Sequencing 13.25.5. MALDI-TOF 13.25.6. Allele Specific Oligonucleotide (ASO) Probes 13.25.7. Others 13.26. Rest of Asia Pacific Genotyping Market Forecast, by End User 13.26.1. Pharmaceutical & Biopharmaceutical Companies 13.26.2. Diagnostic & Research Laboratories 13.26.3. Academic Institutes 13.27. Asia Pacific Genotyping Market Attractiveness Analysis 13.27.1. By Product 13.27.2. By Technology 13.27.3. By End User 13.28. PEST Analysis 13.29. Key Trends 13.30. Key Developments 14. Middle East & Africa Genotyping Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Genotyping Market Overview 14.3. Middle East & Africa Genotyping Market Value Share Analysis, by Product 14.4. Middle East & Africa Genotyping Market Forecast, by Product 14.4.1. Reagents & Kits 14.4.2. Genotyping Services 14.4.3. Instruments 14.4.3.1. Sequencers & Amplifiers 14.4.3.2. Analyzers 14.4.4. Others 14.5. Middle East & Africa Genotyping Market Value Share Analysis, by Technology 14.6. Middle East & Africa Genotyping Market Forecast, by Technology 14.6.1. Microarrays 14.6.2. Capillary Electrophoresis 14.6.2.1. Amplified Fragment Length Polymorphism (AFLP) 14.6.2.2. Restriction Fragment Length Polymorphism (RFLP) 14.6.2.3. Single-Strand Conformation Polymorphism (SSCP) 14.6.3. Polymerase Chain Reaction (PCR) 14.6.3.1. Real-Time PCR 14.6.3.2. Digital PCR 14.6.4. Sequencing 14.6.4.1. Next-Generation Sequencing 14.6.4.2. Pyrosequencing 14.6.4.3. Sanger Sequencing 14.6.5. MALDI-TOF 14.6.6. Allele Specific Oligonucleotide (ASO) Probes 14.6.7. Others 14.7. Middle East & Africa Genotyping Market Value Share Analysis, by End User 14.8. Middle East & Africa Genotyping Market Forecast, by End User 14.8.1. Pharmaceutical & Biopharmaceutical Companies 14.8.2. Diagnostic & Research Laboratories 14.8.3. Academic Institutes 14.9. Middle East & Africa Genotyping Market Value Share Analysis, by Country 14.10. Middle East & Africa Genotyping Market Forecast, by Country 14.10.1. GCC 14.10.2. South Africa 14.10.3. Rest of Middle East & Africa 14.11. Middle East & Africa Genotyping Market Analysis, by Country 14.12. GCC Genotyping Market Forecast, by Product 14.12.1. Reagents & Kits 14.12.2. Genotyping Services 14.12.3. Instruments 14.12.3.1. Sequencers & Amplifiers 14.12.3.2. Analyzers 14.12.4. Others 14.13. GCC Genotyping Market Forecast, by Technology 14.13.1. Microarrays 14.13.2. Capillary Electrophoresis 14.13.2.1. Amplified Fragment Length Polymorphism (AFLP) 14.13.2.2. Restriction Fragment Length Polymorphism (RFLP) 14.13.2.3. Single-Strand Conformation Polymorphism (SSCP) 14.13.3. Polymerase Chain Reaction (PCR) 14.13.3.1. Real-Time PCR 14.13.3.2. Digital PCR 14.13.4. Sequencing 14.13.4.1. Next-Generation Sequencing 14.13.4.2. Pyrosequencing 14.13.4.3. Sanger Sequencing 14.13.5. MALDI-TOF 14.13.6. Allele Specific Oligonucleotide (ASO) Probes 14.13.7. Others 14.14. GCC Genotyping Market Forecast, by End User 14.14.1. Pharmaceutical & Biopharmaceutical Companies 14.14.2. Diagnostic & Research Laboratories 14.14.3. Academic Institutes 14.15. South Africa Genotyping Market Forecast, by Product 14.15.1. Reagents & Kits 14.15.2. Genotyping Services 14.15.3. Instruments 14.15.3.1. Sequencers & Amplifiers 14.15.3.2. Analyzers 14.15.4. Others 14.16. South Africa Genotyping Market Forecast, by Technology 14.16.1. Microarrays 14.16.2. Capillary Electrophoresis 14.16.2.1. Amplified Fragment Length Polymorphism (AFLP) 14.16.2.2. Restriction Fragment Length Polymorphism (RFLP) 14.16.2.3. Single-Strand Conformation Polymorphism (SSCP) 14.16.3. Polymerase Chain Reaction (PCR) 14.16.3.1. Real-Time PCR 14.16.3.2. Digital PCR 14.16.4. Sequencing 14.16.4.1. Next-Generation Sequencing 14.16.4.2. Pyrosequencing 14.16.4.3. Sanger Sequencing 14.16.5. MALDI-TOF 14.16.6. Allele Specific Oligonucleotide (ASO) Probes 14.16.7. Others 14.17. South Africa Genotyping Market Forecast, by End User 14.17.1. Pharmaceutical & Biopharmaceutical Companies 14.17.2. Diagnostic & Research Laboratories 14.17.3. Academic Institutes 14.18. Rest of Middle East & Africa Genotyping Market Forecast, by Product 14.18.1. Reagents & Kits 14.18.2. Genotyping Services 14.18.3. Instruments 14.18.3.1. Sequencers & Amplifiers 14.18.3.2. Analyzers 14.18.4. Others 14.19. Rest of Middle East & Africa Genotyping Market Forecast, by Technology 14.19.1. Microarrays 14.19.2. Capillary Electrophoresis 14.19.2.1. Amplified Fragment Length Polymorphism (AFLP) 14.19.2.2. Restriction Fragment Length Polymorphism (RFLP) 14.19.2.3. Single-Strand Conformation Polymorphism (SSCP) 14.19.3. Polymerase Chain Reaction (PCR) 14.19.3.1. Real-Time PCR 14.19.3.2. Digital PCR 14.19.4. Sequencing 14.19.4.1. Next-Generation Sequencing 14.19.4.2. Pyrosequencing 14.19.4.3. Sanger Sequencing 14.19.5. MALDI-TOF 14.19.6. Allele Specific Oligonucleotide (ASO) Probes 14.19.7. Others 14.20. Rest of Middle East & Africa Genotyping Market Forecast, by End User 14.20.1. Pharmaceutical & Biopharmaceutical Companies 14.20.2. Diagnostic & Research Laboratories 14.20.3. Academic Institutes 14.21. Middle East & Africa Genotyping Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Technology 14.21.3. By End User 14.22. PEST Analysis 14.23. Key Trends 14.24. Key Developments 15. South America Genotyping Market Analysis 15.1. Key Findings 15.2. South America Genotyping Market Overview 15.3. South America Genotyping Market Value Share Analysis, by Product 15.4. South America Genotyping Market Forecast, by Product 15.4.1. Reagents & Kits 15.4.2. Genotyping Services 15.4.3. Instruments 15.4.3.1. Sequencers & Amplifiers 15.4.3.2. Analyzers 15.4.4. Others 15.5. South America Genotyping Market Value Share Analysis, by Technology 15.6. South America Genotyping Market Forecast, by Technology 15.6.1. Microarrays 15.6.2. Capillary Electrophoresis 15.6.2.1. Amplified Fragment Length Polymorphism (AFLP) 15.6.2.2. Restriction Fragment Length Polymorphism (RFLP) 15.6.2.3. Single-Strand Conformation Polymorphism (SSCP) 15.6.3. Polymerase Chain Reaction (PCR) 15.6.3.1. Real-Time PCR 15.6.3.2. Digital PCR 15.6.4. Sequencing 15.6.4.1. Next-Generation Sequencing 15.6.4.2. Pyrosequencing 15.6.4.3. Sanger Sequencing 15.6.5. MALDI-TOF 15.6.6. Allele Specific Oligonucleotide (ASO) Probes 15.6.7. Others 15.7. South America Genotyping Market Value Share Analysis, by End User 15.8. South America Genotyping Market Forecast, by End User 15.8.1. Pharmaceutical & Biopharmaceutical Companies 15.8.2. Diagnostic & Research Laboratories 15.8.3. Academic Institutes 15.9. South America Genotyping Market Value Share Analysis, by Country 15.10. South America Genotyping Market Forecast, by Country 15.10.1. Brazil 15.10.2. Mexico 15.10.3. Rest of South America 15.11. South America Genotyping Market Analysis, by Country 15.12. Brazil Genotyping Market Forecast, by Product 15.12.1. Reagents & Kits 15.12.2. Genotyping Services 15.12.3. Instruments 15.12.3.1. Sequencers & Amplifiers 15.12.3.2. Analyzers 15.12.4. Others 15.13. Brazil Genotyping Market Forecast, by Technology 15.13.1. Microarrays 15.13.2. Capillary Electrophoresis 15.13.2.1. Amplified Fragment Length Polymorphism (AFLP) 15.13.2.2. Restriction Fragment Length Polymorphism (RFLP) 15.13.2.3. Single-Strand Conformation Polymorphism (SSCP) 15.13.3. Polymerase Chain Reaction (PCR) 15.13.3.1. Real-Time PCR 15.13.3.2. Digital PCR 15.13.4. Sequencing 15.13.4.1. Next-Generation Sequencing 15.13.4.2. Pyrosequencing 15.13.4.3. Sanger Sequencing 15.13.5. MALDI-TOF 15.13.6. Allele Specific Oligonucleotide (ASO) Probes 15.13.7. Others 15.14. Brazil Genotyping Market Forecast, by End User 15.14.1. Pharmaceutical & Biopharmaceutical Companies 15.14.2. Diagnostic & Research Laboratories 15.14.3. Academic Institutes 15.15. Mexico Genotyping Market Forecast, by Product 15.15.1. Reagents & Kits 15.15.2. Genotyping Services 15.15.3. Instruments 15.15.3.1. Sequencers & Amplifiers 15.15.3.2. Analyzers 15.15.4. Others 15.16. Mexico Genotyping Market Forecast, by Technology 15.16.1. Microarrays 15.16.2. Capillary Electrophoresis 15.16.2.1. Amplified Fragment Length Polymorphism (AFLP) 15.16.2.2. Restriction Fragment Length Polymorphism (RFLP) 15.16.2.3. Single-Strand Conformation Polymorphism (SSCP) 15.16.3. Polymerase Chain Reaction (PCR) 15.16.3.1. Real-Time PCR 15.16.3.2. Digital PCR 15.16.4. Sequencing 15.16.4.1. Next-Generation Sequencing 15.16.4.2. Pyrosequencing 15.16.4.3. Sanger Sequencing 15.16.5. MALDI-TOF 15.16.6. Allele Specific Oligonucleotide (ASO) Probes 15.16.7. Others 15.17. Mexico Genotyping Market Forecast, by End User 15.17.1. Pharmaceutical & Biopharmaceutical Companies 15.17.2. Diagnostic & Research Laboratories 15.17.3. Academic Institutes 15.18. Rest of South America Genotyping Market Forecast, by Product 15.18.1. Reagents & Kits 15.18.2. Genotyping Services 15.18.3. Instruments 15.18.3.1. Sequencers & Amplifiers 15.18.3.2. Analyzers 15.18.4. Others 15.19. Rest of South America Genotyping Market Forecast, by Technology 15.19.1. Microarrays 15.19.2. Capillary Electrophoresis 15.19.2.1. Amplified Fragment Length Polymorphism (AFLP) 15.19.2.2. Restriction Fragment Length Polymorphism (RFLP) 15.19.2.3. Single-Strand Conformation Polymorphism (SSCP) 15.19.3. Polymerase Chain Reaction (PCR) 15.19.3.1. Real-Time PCR 15.19.3.2. Digital PCR 15.19.4. Sequencing 15.19.4.1. Next-Generation Sequencing 15.19.4.2. Pyrosequencing 15.19.4.3. Sanger Sequencing 15.19.5. MALDI-TOF 15.19.6. Allele Specific Oligonucleotide (ASO) Probes 15.19.7. Others 15.20. Rest of South America Genotyping Market Forecast, by End User 15.20.1. Pharmaceutical & Biopharmaceutical Companies 15.20.2. Diagnostic & Research Laboratories 15.20.3. Academic Institutes 15.21. South America Genotyping Market Attractiveness Analysis 15.21.1. By Product 15.21.2. By Technology 15.21.3. By End User 15.22. PEST Analysis 15.23. Key Trends 15.24. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, End Users and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and End Users 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. GE Healthcare GmbH 16.3.1.1. Company Overview 16.3.1.2. Financial Overview 16.3.1.3. Product Portfolio 16.3.1.4. Business Strategy 16.3.1.5. Recent Developments 16.3.1.6. Development Footprint 16.3.2. Illumina, Inc. 16.3.3. Beckman Coulter, Inc. 16.3.4. Life Technologies Corporation 16.3.5. ThermoFisher Scientific, Inc. 16.3.6. Eurofins Scientific 16.3.7. Qiagen NV 16.3.8. Roche Diagnostics 16.3.9. Affymetrix, Inc. 16.3.10. Agilent Technologies, Inc. 16.3.11. Genewiz, Inc. 16.3.12. Fludigm Corporation 16.3.13. Bio-Rad Laboratories, INC. 16.3.14. Sequenom, Inc. 16.3.15. Bioline 16.3.16. Danaher 16.3.17. F. Hoffmann-La Roche Ltd. 16.3.18. Sequenom 16.3.19. Biogeniq Inc. 16.3.20. Envigo 16.3.21. LGC Biosearch Technologies 17. Primary Key Insights

About This Report

Report ID52834
Category Healthcare
Published DateFeb 2020
Updated Date
Contact Us